Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2004

01-09-2004 | Article

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery

Authors: K. Krobot, D. Yin, Q. Zhang, S. Sen, A. Altendorf-Hofmann, J. Scheele, W. Sendt

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2004

Login to get access

Abstract

To assess the significance of initial empiric parenteral antibiotic therapy in patients requiring surgery for community-acquired secondary peritonitis, 425 patients hospitalized between January 1999 and September 2001 in 20 clinics across Germany were followed for a total of 6,521 patient days. Perforated appendix (38%), colon (27%), or gastroduodenum (22%) were the most common sites of infection. Escherichia coli was the most common pathogen. A total of 54 (13%) patients received inappropriate initial parenteral therapy not covering all bacteria isolated, or not covering both aerobes and anaerobes in the absence of culture results. Clinical success, predefined as the infection resolving with initial or step-down therapy after primary surgery, was achieved in 322 patients (75.7%; 95% confidence interval (CI), 70.6–81.2). Patients were more likely to have clinical success if initial antibiotic therapy was appropriate (78.6%; 95% CI, 73.6–83.9) rather than inappropriate (53.4%; 95% CI, 41.1–69.3). Patients having clinical success were estimated to stay 13.9 days in hospital (95% CI, 13.1–14.7), while those who had clinical failure stayed 19.8 days (95% CI, 17.3–22.3). In conclusion, appropriateness of initial parenteral antibiotic therapy was a predictor of clinical success, which in turn was associated with length of stay.
Literature
1.
go back to reference Pacelli P, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D, Crucitti F (1996) Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg 131:641–645PubMed Pacelli P, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D, Crucitti F (1996) Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg 131:641–645PubMed
2.
go back to reference Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. Arch Surg 131:1193–1201PubMed Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M (1996) Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. Arch Surg 131:1193–1201PubMed
3.
go back to reference Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP (1992) Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Arch Surg 127:83–89PubMed Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP (1992) Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Arch Surg 127:83–89PubMed
4.
go back to reference Solomkin JS, Hemsell DL, Sweet R, Tally F, Bartlett J (1992) Evaluation of new antifungal drugs for the treatment of intraabdominal infections. Clin Infect Dis 15(Suppl 1):33–42PubMed Solomkin JS, Hemsell DL, Sweet R, Tally F, Bartlett J (1992) Evaluation of new antifungal drugs for the treatment of intraabdominal infections. Clin Infect Dis 15(Suppl 1):33–42PubMed
5.
go back to reference Hopkins JA, John CH, Wilson SE (1993) Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg 59:791–796PubMed Hopkins JA, John CH, Wilson SE (1993) Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg 59:791–796PubMed
6.
go back to reference Kollef MH, Sherman G, Ward S, Fraser V (1999) Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser V (1999) Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed
7.
go back to reference Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420PubMed Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420PubMed
8.
go back to reference Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685PubMed Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685PubMed
9.
go back to reference Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Miscall GB, Fry DE (1991) Antibiotic treatment for surgical peritonitis. Ann Surg 214:543–549PubMed Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Miscall GB, Fry DE (1991) Antibiotic treatment for surgical peritonitis. Ann Surg 214:543–549PubMed
10.
go back to reference Davey P, Libby G, Hunter K, Broomhall J, Kofteridid D (2001) How important is appropriate empirical antibiotic treatment for intra-abdominal infections? Value Health 4:126–127 Davey P, Libby G, Hunter K, Broomhall J, Kofteridid D (2001) How important is appropriate empirical antibiotic treatment for intra-abdominal infections? Value Health 4:126–127
11.
go back to reference Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, Gene RJ (2000) Community-acquired pneumonia. Etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 118:1344–1354CrossRefPubMed Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, Fuenzalida AD, Gene RJ (2000) Community-acquired pneumonia. Etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 118:1344–1354CrossRefPubMed
12.
go back to reference Der Bundesminister für Gesundheit (ed) (1993) Internationale Klassifikation der Krankheiten (ICD), 9. Revision, 2nd edn. Kohlhammer, Köln Der Bundesminister für Gesundheit (ed) (1993) Internationale Klassifikation der Krankheiten (ICD), 9. Revision, 2nd edn. Kohlhammer, Köln
13.
go back to reference DIMDI (ed) Internationale Klassifikation der Krankheiten und verwandter Gesundheitsprobleme (ICD), 10 Revision. Bd II, Diagnosenthesaurus Version 3.0. Kohlhammer, Köln DIMDI (ed) Internationale Klassifikation der Krankheiten und verwandter Gesundheitsprobleme (ICD), 10 Revision. Bd II, Diagnosenthesaurus Version 3.0. Kohlhammer, Köln
14.
go back to reference Greenland S, Drescher K (1993) Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 49:865–872PubMed Greenland S, Drescher K (1993) Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 49:865–872PubMed
15.
go back to reference Collet D (1994) Modeling survival data in medical research. Chapman & Hall, London, p 123 Collet D (1994) Modeling survival data in medical research. Chapman & Hall, London, p 123
16.
go back to reference Klein JP, Moeschberger ML (1997) Survival analysis: techniques for censored and truncated data. Springer, New York Berlin Heidelberg, p 110 Klein JP, Moeschberger ML (1997) Survival analysis: techniques for censored and truncated data. Springer, New York Berlin Heidelberg, p 110
17.
go back to reference Chabot I, Yin D, Iskedjian M (2002) Effect of inappropriate initial antibiotic therapy on outcomes of patients hospitalized with complicated intra-abdominal infections in Canada. In: Program and abstracts, 40th Annual Meeting of Infectious Disease Society of America (abstract no. 604) Chabot I, Yin D, Iskedjian M (2002) Effect of inappropriate initial antibiotic therapy on outcomes of patients hospitalized with complicated intra-abdominal infections in Canada. In: Program and abstracts, 40th Annual Meeting of Infectious Disease Society of America (abstract no. 604)
18.
go back to reference Cattan P, Rotman N, Houssin D (2004) Outcomes of empiric antibiotic therapy for hospitalized patients with community-acquired intra-abdominal infection. Eur J Clin Microbiol Infect Dis (in press) Cattan P, Rotman N, Houssin D (2004) Outcomes of empiric antibiotic therapy for hospitalized patients with community-acquired intra-abdominal infection. Eur J Clin Microbiol Infect Dis (in press)
19.
go back to reference Bare M, Castells X, Garcia A (2002) Excess mortality associated with inappropriate initial empiric antibiotic therapy in patients undergoing surgery for intra-abdominal infection. Clin Microbiol Infect 8(Suppl 1):30 Bare M, Castells X, Garcia A (2002) Excess mortality associated with inappropriate initial empiric antibiotic therapy in patients undergoing surgery for intra-abdominal infection. Clin Microbiol Infect 8(Suppl 1):30
20.
go back to reference Arlington medical resources (2000) The hospital anti-infective market guide. German edition. Arlington Medical Resources, Malvern, p 1 (Table 126)MATH Arlington medical resources (2000) The hospital anti-infective market guide. German edition. Arlington Medical Resources, Malvern, p 1 (Table 126)MATH
Metadata
Title
Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery
Authors
K. Krobot
D. Yin
Q. Zhang
S. Sen
A. Altendorf-Hofmann
J. Scheele
W. Sendt
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1199-0

Other articles of this Issue 9/2004

European Journal of Clinical Microbiology & Infectious Diseases 9/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.